La Jolla, CA, United States
La Jolla, CA, United States

Time filter

Source Type

Patent
Afraxis Inc. | Date: 2012-11-02

Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of Fragile X syndrome.


Patent
Afraxis Inc. | Date: 2014-08-14

Provided herein are PAK inhibitors. Also provided herein are compositions and methods for treating an individual suffering from schizophrenia


Patent
Afraxis Inc. | Date: 2014-04-30

Compounds having the formula I, or a pharmaceutically acceptable salt thereof, wherein R^(1), R^(2), X^(1), X^(2), and Ar are as defined herein, are inhibitors of PAK1. Also disclosed are compositions and methods for treating cancer and hyperproliferative disorders.


Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders such as neuropsychiatric disorders or neurofibromatosis. Also described herein are methods of utilizing PAK inhibitors for the treatment of cancer.


Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders such as neuropsychiatric disorders.


Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders such as neuropsychiatric disorders.


Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders.


Patent
Afraxis Inc. | Date: 2012-12-07

Provided herein are methods of utilizing PAK inhibitors for the treatment of cancer. Further provided herein are compounds and formulations utilized for the treatment of cancer.


Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders.


Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of cell proliferative disorders and/or CNS disorders.

Loading Afraxis Inc. collaborators
Loading Afraxis Inc. collaborators